Perceptive Advisors LLC Puma Biotechnology, Inc. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $23.3 Million - $33.8 Million	-564,579 Closed	0 $0
Q2 2018 Nov 01, 2018	BUY	$48.3 - $68.25 $4.83 Million - $6.83 Million	100,000 Added 21.52%	564,579 $27.7 Million
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $1.08 Million - $1.53 Million	22,400 Added 5.07%	464,579 $27.5 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $15.6 Million - $26 Million	-261,641 Reduced 37.17%	442,179 $30.1 Million
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $20.6 Million - $29.1 Million	-220,000 Reduced 23.81%	703,820 $69.6 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $66.5 Million - $111 Million	923,820	923,820 $111 Million

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.